Cas 1217859-30-7,4-(2-(dicyanomethylene)-4-oxothiazolidin-3-yl)-N-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide

1217859-30-7

Post Buying Request

Basic information

Product Name: 4-(2-(dicyanomethylene)-4-oxothiazolidin-3-yl)-N-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide
Synonyms: 4-(2-(dicyanomethylene)-4-oxothiazolidin-3-yl)-N-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide
CAS NO:1217859-30-7
Molecular Formula:
Molecular Weight: 434.48
EINECS: N/A
Product Categories: N/A
Mol File: 1217859-30-7.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(2-(dicyanomethylene)-4-oxothiazolidin-3-yl)-N-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide(CAS DataBase Reference)
NIST Chemistry Reference: 4-(2-(dicyanomethylene)-4-oxothiazolidin-3-yl)-N-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide(1217859-30-7)
EPA Substance Registry System: 4-(2-(dicyanomethylene)-4-oxothiazolidin-3-yl)-N-(4-methoxy-1,2,5-thiadiazol-3-yl)benzenesulfonamide(1217859-30-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1217859-30-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1217859-30-7 Suppliers

Recommended suppliersmore

1217859-30-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1217859-30-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,8,5 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1217859-30:
(9*1)+(8*2)+(7*1)+(6*7)+(5*8)+(4*5)+(3*9)+(2*3)+(1*0)=167
167 % 10 = 7
So 1217859-30-7 is a valid CAS Registry Number.

1217859-30-7Upstream product

1217859-30-7Downstream Products

1217859-30-7Relevant articles and documents

Synthesis of thiazolidine and thiophene derivatives for evaluation as anticancer agents

El-Gaby,Ismail,Abdel-Gawad,Aly,Ghorab

experimental part, p. 2645 - 2654 (2010/04/05)

The non-isolated adducts (3a,b) were used as key intermediates to synthesize some novel thiazolidine and thiophene derivatives. Compound (4) exhibited a remarkable antitumor activity against EAC cells compared with the Doxorubicin as a positive control. T

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1217859-30-7